Morbidity in COPD results from a combination of factors including hypoxia-induced pulmonary hypertension, in part due to pulmonary vascular remodelling.
COPD的发病是多因素综合作用的结果，其中包括组织缺氧所引起的肺动脉高压，而组织缺氧部分归因于肺血管的重塑。
Objective: to find a therapeutic inhibitor of vascular remodelling in pulmonary hypertension.
目的：寻找抑制肺动脉高压肺血管重建的药物。
应用推荐